| Descriptor English: | Matrix Metalloproteinase 17 | ||||||
| Descriptor Spanish: |
Metaloproteinasa 17 de la Matriz
| ||||||
| Descriptor Portuguese: | Metaloproteinase 17 da Matriz | ||||||
| Descriptor French: | Matrix metalloproteinase 17 | ||||||
| Entry term(s): |
MMP 17 Metalloproteinase MMP-17 Metalloproteinase MMP17 Metalloproteinase MT-MMP-4 MT4 Matrix Metalloproteinase MT4-MMP MT4-Matrix Metalloproteinase Membrane Type 4 Matrix Metalloproteinase Membrane Type Matrix Metalloproteinase 4 Membrane-Type 4 Matrix Metalloproteinase Membrane-Type Matrix Metalloproteinase 4 Metalloproteinase 17, Matrix Metalloproteinase, MMP-17 Metalloproteinase, MMP17 |
||||||
| Tree number(s): |
D08.811.277.656.300.480.525.300.650 D08.811.277.656.675.374.525.300.875 D12.776.395.550.448.700 D12.776.543.484.500.700 D12.776.543.550.418.700 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D053515 | ||||||
| Scope note: | A membrane-type metalloproteinase that is associated with the CELL MEMBRANE via a GLYCOSYL-PHOSPHATIDYLINOSITOL linkage. It is synthesized as an inactive zymogen that is activated by the action of PROPROTEIN CONVERTASES such as FURIN. |
||||||
| Allowable Qualifiers: |
AD administration & dosage AE adverse effects AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
| Entry Combination: |
antagonists & inhibitors:Matrix Metalloproteinase Inhibitors
|
||||||
| Registry Number: | EC 3.4.24.- | ||||||
| Public MeSH Note: | 2007; MATRIX METALLOPROTEINASE 17 was indexed under MATRIX METALLOPROTEINASES 2006 & under METALLOENDOPEPTIDASES 1994-2005 |
||||||
| History Note: | 2007(2005) |
||||||
| DeCS ID: | 52236 | ||||||
| Unique ID: | D053515 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 2007/01/01 | ||||||
| Date of Entry: | 2006/07/05 | ||||||
| Revision Date: | 2012/07/03 |
-
-
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes -
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
|
Matrix Metalloproteinase 17
- Preferred
| Concept UI |
M0485717 |
| Scope note | A membrane-type metalloproteinase that is associated with the CELL MEMBRANE via a GLYCOSYL-PHOSPHATIDYLINOSITOL linkage. It is synthesized as an inactive zymogen that is activated by the action of PROPROTEIN CONVERTASES such as FURIN. |
| Preferred term | Matrix Metalloproteinase 17 |
| Entry term(s) |
MMP 17 Metalloproteinase MMP-17 Metalloproteinase MMP17 Metalloproteinase MT-MMP-4 MT4 Matrix Metalloproteinase MT4-MMP MT4-Matrix Metalloproteinase Membrane Type 4 Matrix Metalloproteinase Membrane Type Matrix Metalloproteinase 4 Membrane-Type 4 Matrix Metalloproteinase Membrane-Type Matrix Metalloproteinase 4 Metalloproteinase 17, Matrix Metalloproteinase, MMP-17 Metalloproteinase, MMP17 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
